1 week Ago By ABMN Staff
New York Life Investment Management LLC boosted its stake in shares of Zoetis Inc. ( NYSE:ZTS – Free Report ) by 0.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The firm owned 70,302 shares of the company’s stock after purchasing an additional 390 shares during the period. New York Life Investment Management LLC’s holdings in Zoetis were worth $12,188,000 at the end of the most recent reporting period. A number of other large investors also recently bought and sold shares of ZTS.
International Assets Investment Management LLC raised its stake in Zoetis by 40.7% during the fourth quarter. International Assets Investment Management LLC now owns 2,429 shares of the company’s stock worth $479,000 after purchasing an additional 703 shares during the period.
Aveo Capital Partners LLC acquired a new stake in Zoetis during the 4th quarter valued at $225,000. Gryphon Financial Partners LLC grew its holdings in Zoetis by 11.8% during the 4th quarter.
Gryphon Financial Partners LLC now owns 3,056 shares of the company’s stock valued at $601,000 after purchasing an additional 322 shares in the last quarter. Principal Securities Inc. acquired a new stake in Zoetis during the 4th quarter valued at $1,625,000.
Finally, Northwest Financial Advisors acquired a new stake in Zoetis during the 4th quarter valued at $54,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.
Analyst Upgrades and Downgrades Several research analysts have weighed in on the stock. Stifel Nicolaus reissued a “buy” rating and set a $200.00 price objective on shares of Zoetis in a report on Tuesday, August 27th.
Piper Sandler raised their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th.
Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Finally, BTIG Research raised their price target on shares of Zoetis from $220.00 to $225.
00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.
com, the company has an average rating of “Buy” and a consensus price target of $217.11. Zoetis Stock Up 1.
4 % ZTS stock opened at $189.23 on Friday. The company has a debt-to-equity ratio of 1.
32, a current ratio of 3.45 and a quick ratio of 2.09.
The company has a 50-day moving average of $181.22 and a two-hundred day moving average of $174.49.
The stock has a market capitalization of $85.73 billion, a price-to-earnings ratio of 36.46, a price-to-earnings-growth ratio of 2.
87 and a beta of 0.88. Zoetis Inc.
has a 52-week low of $144.80 and a 52-week high of $201.92.
Zoetis ( NYSE:ZTS – Get Free Report ) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.
49 by $0.07. Zoetis had a net margin of 26.
29% and a return on equity of 50.67%. The business had revenue of $2.
36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same quarter in the prior year, the business earned $1.
41 earnings per share. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis.
As a group, equities research analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current year.
Zoetis Profile ( Free Report ) Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. Featured Stories Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Zoetis Inc. ( NYSE:ZTS – Free Report ). Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.
com's FREE daily email newsletter ..
